Intraoperative Fluid Restriction in Pancreatic Surgery: A Double Blinded Randomised Controlled Trial

PLoS One. 2015 Oct 14;10(10):e0140294. doi: 10.1371/journal.pone.0140294. eCollection 2015.

Abstract

Background: Perioperative fluid restriction in a variety of operations has shown improvement of: complications, recovery of gastrointestinal function and length of stay (LOS). We investigated effects of crystalloid fluid restriction in pancreatic surgery. Our hypothesis: enhanced recovery of gastrointestinal function.

Methods: In this double-blinded randomized trial, patients scheduled to undergo pancreatoduodenectomy (PD) were randomized: standard (S:10ml/kg/hr) or restricted (R:5ml/kg/hr) fluid protocols.

Primary endpoint: gastric emptying scintigraphically assessed on postoperative day 7.

Results: In 66 randomized patients, complications and 6-year survival were analyzed. 54 patients were analyzed in intention to treat: 24 S-group and 30 R-group. 32 patients actually underwent a PD and 16 patients had a palliative gastrojejunostomy bypass operation in the full protocol analysis. The median gastric emptying time (T½) was 104 minutes (S-group, 95% confidence interval: 74-369) versus 159 minutes (R-group, 95% confidence interval: 61-204) (P = 0.893, NS). Delayed gastric emptying occurred in 10 patients in the S-group and in 13 patients in the R-group (45% and 50%, P = 0.779, NS). The primary outcome parameter, gastric emptying time, did not show a statistically significant difference between groups.

Conclusion: A fluid regimen of 10ml/kg/hr or 5ml/kg/hr during pancreatic surgery did not lead to statistically significant differences in gastric emptying. A larger study would be needed to draw definite conclusions about fluid restriction in pancreatic surgery.

Trial registration: ISRCTN62621488.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Female
  • Fluid Therapy*
  • Humans
  • Isotonic Solutions / administration & dosage
  • Male
  • Middle Aged
  • Mortality
  • Palliative Care
  • Pancreas / pathology
  • Pancreas / surgery*
  • Pancreaticoduodenectomy / adverse effects
  • Pancreaticoduodenectomy / methods*
  • Postoperative Complications / pathology
  • Postoperative Period
  • Ringer's Lactate
  • Treatment Outcome

Substances

  • Isotonic Solutions
  • Ringer's Lactate

Associated data

  • ISRCTN/ISRCTN62621488

Grants and funding

This study was supported by BBraun for laboratory tests. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.